Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-10-23
1998-11-03
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
058309101
ABSTRACT:
The present invention relates to novel therapeutic uses of certain compounds to protect nerve cells from injury and death. The compounds include cytochalasin D and related analogs, and cytochalasin E and related analogs.
REFERENCES:
Baines, A.J. In: R.D. Burgoyne (ed) The Neuronal Cytoskeleton. Wiley-Liss, New York, pp. 161-193 (1991).
Bamburg, J.R., & Bernstein, B.W. In: R.D. Burgoyne (ed) The Neuronal Cytoskeleton. Wiley-Liss, New York, pp. 121-160 (1991).
Bear, M.F. & Malenka, R.C. Curr. Opin. Neurobiol. 4, 389-399 (1994).
Bencherif, M., & Lukas, R.J. J. Neurochem. 61, 852-864 (1993).
Bonventre, J.V., Phospholipase A.sub.2 and signal transduction. J. Am. Soc. Nephrol. 3:128-150; 1992.
Choi, D.W. Neuron 1, 623-634 (1988).
DeBoni, U. et al., Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate. J. Neurol. Sci. 68:105-118; 1985.
DeLorenzo, R.J., Antiepileptic Drugs, Third Edition; Raven Press, Ltd., 1989.
Elliott, E.M. et al., Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61:57-67; 1993.
Goodman, Y. et al., Secreted forms of .beta.APP protect hippocampal neurons against A.beta. toxicity and oxidative injury. Soc. Neurosci. Abstr., 19:1251; 1993.
Haass, C. et al., Amyloid .beta.-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325; 1992.
Hope, W.C. et al., In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem. Pharmacol. 32: 367-371; 1983.
Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahishi, J., Murakata, C., Sato, A., and Kaneko, M., K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142:436-440; 1987.
Kelly, R.B. Cell/Neuron 72/10 (Suppl), 43-53 (1993).
Khachaturian, Z.S., The role of calcium regulation in brain agina: reexamination of a hypothesis. Aging 1:17-34; 1989.
Kosik, K.S. et al., Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1:817-825; 1988.
Marsh, L., & Letournea, P.C. J. Cell. Biol. 99, 2041-2047 (1984).
Mattson, M.P., Kumar, K., Cheng, B., Wang, H., and Michaelis, E.K., Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons. J. Neurosci. 13:4575-4588, 1993.
Mohr, E. et al., GABA-Agonist therapy for Alzheimer's Disease. Clinical Neuropharmacology 9:257-263; 1986.
Nadler, I.V., & Cuthbertson, G.J. Brain Res. 195, 47-56 (1980).
Nowak, T.S. Jr. et al., Stress protein and proto-oncogene expression as indicators of neuronal pathophysiology after ischemia. Prog. Brain Res. 96:195-208; 1993.
Perry, G. et al., Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 84:3030-3036; 1987.
Rayevsky, K.S. et al., GABA-ergic drugs: effects on conditioning, memory, and learning. Pharmacol. Res. Commun. 15:85-96; 1983.
Rose, K. et al., Nordihydroguaiaretic acid potentiates rapidly triggered excitotoxic injury in murine cortical cell cultures. Soc. Neurosci. Abstr. 17:784; 1991.
Rothman, S., & Olney, J.W. Ann. Neurol. 19, 105-111 (1986).
Sapolsky, R.M. et al., The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis, Endocrine Reviews, vol. 7, No. 3, pp. 284-301 (1986).
Shoji, J. et al., Production of the Alzheimer amyloid .beta. protein by normal proteolytic processing. Science 258:126-129; 1992.
Simmons, L.K. et al., Secondary structure of amyloid .beta. peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 1994, In press.
Smith, et al., Excess brain protein oxidation and enxyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 88:10540-10543; 1991.
Sternlicht, H., & Ringel, I., J. Biol. Chem. 254, 10540-10550 (1979).
Watanabe, Y. et al., Phenytoin prevents stress and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 2:431-435; 1992.
Wolozin, B.L. et al., A neuronal antigen in the brains of Alzheimer's patients. Science 232:648-650; 1986.
Arispe, N. et al., Alzheimer disease amyloid .beta. protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90:567-571; 1993.
Bading, H. et al., Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253:912-914; 1991.
Behl, C. et al., Vitamin E protects nerve cells for amyloid .beta. protein toxicity. Biochem. Biophys. Res. Commun. 186:944-950; 1992.
Bleck, T.P., Convulsive disorders: status epilepticus. Clin. Neuropharmacol. 14:191-198; 1991.
Boxer, P.A. et al., Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 21:III47-III51; 1990.
Breitner, J.C.S. et al., Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-232; 1994.
Busciglio, J. et al., Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13:609-612; 1992.
Cai, X.D. et al., Release of excess amyloid .beta. protein from a mutant amyloid .beta. protein precusor. Science 259:514-516; 1993.
Cai, Z. et al., Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca.sup.2+ level in neuronal culture. Eur. J. Pharmacol. 219:53-57; 1992.
Callazo, D., Takahashi, H., and McKay, R.D.G., Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 9:643-656; 1992.
Cantiello, H.F., Stow, J.L., Prat, A.G., & Ausiello, D.A. Actin filaments regulate epithelial Na+ channel activity. Am. J. Physiol. 261, C882-888 (1991).
Capdevila, J., et al., Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch. Biochem. Biophys. 261:257-263; 1988.
Chartier-Harlin, M.C. et al., Early-onset Alzheimer's disease caused by mutations at codon 717 of the .beta.-amyloid precursor protein gene. Nature 353:844-846; 1991.
Cheng, B., and Mattson, M. P., IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1558-1566; 1992.
Cheng, B. et al., Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF. Exp. Neurol. 117:114-123; 1992.
Cheng, B., Barger, S.W., and Mattson, M.P., Staurosporine, K-252a and K-252b stabilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose. J. Neurochem. 1994, In press.
Choi, D.W., Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:369-379; 1987.
Citron, M. et al., Mutation of the .beta.-amyloid precursor protein in familial Alzheimer's disease increases .beta.-protein production. Nature 360:672-674; 1993.
Clemens, J.S. et al., LY178002 reduces rat brain damage after transient global forebrain ischemia. Stroke 22:1048-1052; 1991.
Copani, A. et al., .beta.-amyloid increases neuronal susceptibility to injury by glucose deprovation. NeuroReport 2:763-675; 1991.
Drewes, G. et al., Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:2131-2138; 1992.
Dumuis, A. et al., NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336:68-70; 1988.
Evans, J.F. et al., 5-lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors. Mol. Pharmacol. 40:22-27; 1991.
Goate, A. et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706; 1991.
Goodman, Y., and Mattson, M.P., Secreted forms of .beta.APP protect hippocampal neurons against A.beta.-peptide-induced oxidative injury. Exp. Neurol. 128:1-12 (1994).
Jarvis William R. A.
University of Kentucky Research Foundation
LandOfFree
Cytochalasins useful in providing protection against nerve cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytochalasins useful in providing protection against nerve cell , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytochalasins useful in providing protection against nerve cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689498